DUBLIN, Ireland, Nov 11, 2008 (BUSINESS WIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/9c5db8/competitor_analysi) has announced the addition of the "Competitor Analysis: Diabetes Drug Pipeline" report to their offering.
This Competitive Intelligence report on the Diabetes Drug Pipeline, as of November 2008 provides a competitor analysis in the development pipeline of novel antidiabetic treatment modalities for type 1 and 2 diabetes. The report includes an overview of the major marketed diabetes drugs and the respective... read more
Submitted by Avera
LEXINGTON, Ky., Nov 10, 2008 /PRNewswire via COMTEX/ -- Every year, the Kentucky Derby brings celebrities from the worlds of Hollywood, sports and politics to Kentucky for the first weekend in May. And, every year, Louisville, Ky., resident Patricia Barnstable Brown hosts the biggest, most extravagant, star-studded Derby party in town -- the Barnstable Brown Gala.
Last year's attendees included Edward Norton, Tom Brady, Nick Lachey, Molly Sims, Bill O'Reilly, Terrell Owens and Hugh... read more
Submitted by Avera
WASHINGTON (Reuters) - Neither vitamin C nor vitamin E supplements cuts the risk of cardiovascular disease including heart attack and stroke in a U.S. study published on Sunday.
And a second study failed to show that taking low-dose aspirin helped prevent heart and artery disease among Japanese people with diabetes.
Many people take vitamin supplements to try to ward off chronic disease. In a study aiming to establish whether they prevent heart disease, 14,641 doctors... read more
Submitted by Avera
WASHINGTON, Nov. 10 /PRNewswire/ -- Patients with diabetes are more than twice as likely as those without the disease to have hearing loss, according to a recent National Institutes of Health (NIH) study. Overall, more than 40 percent of people with diabetes in the study had some degree of hearing loss.
"People with diabetes should ask their doctors to check their hearing. This should be routine," said Sergei Kochkin, Ph.D., executive director of the Better... read more
Submitted by Avera
Nov. 10, 2008 -- Taking low-dose aspirin may not prevent diabetes patients from experiencing heart "events," new research shows.
Those findings come from a new study published in The Journal of the American Medical Association and another study published last month in BMJ. Those two studies don't question the heart benefits of low-dose aspirin in people who already have heart disease. Instead, the new studies are about aspirin's effects on people with diabetes who have... read more
Submitted by Avera
Researchers have revealed they have developed a system which could halve the number of people dying from a diabetes-related condition.
Studies carried out in Edinburgh show that patients suffering from a diabetic foot ulcer could win their battle if their heart health is treated at the same time.
Experts at the city's Royal Infirmary now believe that a simple system of heart monitoring, combined with the use of preventative medicines, could save tens of thousands... read more
Submitted by Avera
Because scientists often tend to dismiss what they don't fully understand, many of them used to think that C-peptide had no physiological function. But while it's true that C-peptide does nothing to lower blood sugar, recent research is finding that it might have a role in preventing diabetes complications.
C-peptide binds to cell surfaces and activates cell-signaling pathways, stimulating enzymes that usually have reduced activity in people with type 1.
Pancreas transplants promote... read more
Submitted by Avera
A British study of 800 people 65 and older concludes that people with diabetes are more likely than non-diabetics to experience difficulties walking, dressing and climbing stairs.
Researchers at the University of Bedfordshire found that 46 percent of older people with diabetes relied on some sort of walking aid, such as a cane or walker, versus 31 percent of elderly people without diabetes. The study also found that 4 percent of people with diabetes... read more
Submitted by Avera
Lawrence Lavery, DPM, podiatrist at Scott & White Memorial Hospital in Temple, Texas, clearly understands the diabetic foot.
That skill has resulted in the award of $10 million in private and government grants for Lavery’s projects over the years, and has helped create a body of work that, arguably, has prevented many deaths, as well as thousands of amputations, among people with diabetes.
Indeed, says Andrew Boulton, professor of medicine at the University... read more
Submitted by Avera
Researchers at the Stanford University School of Medicine say that scientists looking for genetic variants responsible for triggering early-onset diabetes, also known as type-1 diabetes, may be looking in the wrong place.
The researchers say that type-1 diabetes is an autoimmune disease, which is caused when the immune system attacks and destroys insulin-producing cells in a person’s pancreas.
In a research paper, published in the journal Clinical Immunology, the researchers say that what triggers such... read more
Submitted by Avera